Reduction of protein synthesis and statin-induced cardiomyocyte cell death

Cardiovascular Toxicology

Volumn 7, Issue 1, 2007, Pages 1-9

  Rabkin, Simon W ^a   Lodha, Parth ^a   Kong, Jennifer Y ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cardiomyocyte; Cell death; Lovastatin; Protein synthesis heart

Indexed keywords

CYCLOHEXIMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEUCINE; METHIONINE; MEVINOLIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DEATH; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; EMBRYO; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANIMALS; AUTORADIOGRAPHY; BLOTTING, WESTERN; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CHICK EMBRYO; COLORING AGENTS; CYCLOHEXIMIDE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; MYOCYTES, CARDIAC; PROTEIN SYNTHESIS INHIBITORS;

EID: 34548318655     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12012-007-0003-7     Document Type: Article

References (51)

1. 2+ exchanger. FEBS Letters, 343, 151-154.
2. Caraglia, M., Budillon, A., Vitale, G., Lupoli, G., Tagliaferri, P., & Abbruzzese, A. (2000). Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation. European Journal of Biochemistry, 267, 3919-3936.
3. Coxon, F. P., Benford, H. L., Russell, R. G., & Rogers, M. J. (1998). Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs. Molecular Pharmacology, 54, 631-638.
4. Delerive, P., Martin-Nizard, F., Chinetti, G., Trottein, F., Fruchart, J. C., Najib, J., Duriez, P., & Staels, B. (1999). Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circulation Research, 85, 394-402.
5. Demyanets, S., Kaun, C., Pfaffenberger, S., Hohensinner, P. J., Rega, G., Pammer, J., Maurer, G., Huber, K., & Wojta, J. (2006). Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro. Biochemical Pharmacology, 71, 1324-1330.
6. El-Ani, D., & Zimlichman, R. (2001). Simvastatin induces apoptosis of cultured rat cardiomyocytes. Journal of Basic and Clinical Physiology and Pharmacology, 12, 325-338.
7. Flint, O. P., Masters, B. A., Gregg, R. E., & Durham, S. K. (1997). Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro. Toxicology and Applied Pharmacology, 145, 91-98.
8. Fodstad, O., & Olsnes, S. (1997) Studies on the accessability of ribosomes to inactivation by the toxic lectins abrin and ricin. European Journal of Biochemistry, 74, 209-215.
9. Gozuacik, D., & Kimchi, A. (2004). Autophagy as a cell death and tumor suppressor mechanism. Oncogene, 23, 2891-2906.
10. Hasegawa, H., Yamamoto, R., Takano, H., Mizukami, M., Asakawa, M., Nagai, T., & Komuro, I. (2003). 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the development of cardiac hypertrophy and heart failure in rats. Journal of Molecular and Cellular Cardiology, 35, 953-960.
11. Hayashidani, S., Tsutsui, H., Shiomi, T., Suematsu, N., Kinugawa, S., Ide, T., Wen, J., & Takeshita, A. (2002). Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation, 105, 868-873.
12. Iimura, O., Vrtovsnik, F., Terzi, F., & Friedlander, G. (1997). HMG-CoA reductase inhibitors induce apoptosis in mouse proximal tubular cells in primary culture. Kidney International, 52, 962-972.
13. Indolfi, C., Di Lorenzo, E., Perrino, C., Stingone, A. M., Curcio, A., Torella, D., Cittadini, A., Cardone, L., Coppola, C., Cavuto, L., Arcucci, O., Sacca, L., Avvedimento, E. V., & Chiariello, M. (2002). Hydroxymethylglutaryl coenzyme a reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation. Circulation, 106, 2118-2124.
14. Iordanov, M. S., Paranjape, J. M., Zhou, A., Wong, J., Williams, B. R., Meurs, E. F., Silverman, R. H., & Magun, B. E. (2000). Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: Involvement of RNase L, protein kinase R, and alternative pathways. Molecular and Cellular Biology, 206, 17-27.
15. Ito, M., Adachi, T., Pimentel, D. R., Ido, Y., & Colucci, W. S. (2004). Statins inhibit beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes via a Rac1-dependent mechanism. Circulation, 110, 412-418.
16. Kageyama, A., Kusano, I., Tamura, T., Oda, T., & Muramatsu, T. (2002). Comparison of the apoptosis-inducing abilities of various protein synthesis inhibitors in U937 cells. Bioscience, Biotechnology & Biochemistry, 66, 835-839.
17. Kashiwagi, Y., Haneda, T., Osaki, J., Miyata, S., & Kikuchi, K. (1998). Mechanical stretch activates a pathway linked to mevalonate metabolism in cultured neonatal rat heart cells. Hypertension Researc - Clinical & Experimental, 21, 109-119.
18. Kim, Y. M., Son, K., Hong, S. J., Green, A., Chen, J. J., Tzeng, E., Hierholzer, C., & Billiar, T. R. (1998). Inhibition of protein synthesis by nitric oxide correlates with cytostatic activity: nitric oxide induces phosphorylation of initiation factor eIF-2 alpha. Molecular Medicine, 4, 179-190.
19. Kong, J. Y., & Rabkin, S. W. (2002). Lovastatin does not accentuate but is rather additive to palmitate-induced apoptosis in cardiomyocytes. Prostaglandins, Leukotrienes and Essential Fatty Acids, 67, 293-302.
20. Kong, J. Y., & Rabkin S. W. (2005). The association of RhoB with caspase-2: Changes with lovastatin-induced apoptosis. Biochemistry and Cell Biology, 83, 608-619.
21. Kroemer, G., & El Deiry, W. S., Golstein, P., et al. (2005). Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death and Differentiation, 12(suppl 2), 1463-1467.
22. Kyrklund, C., Backman, J. T., Kivisto, K. T., Neuvonen, M., Laitila, J., & Neuvonen, P. J. (2001). Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate. Clinical Pharmacology and Therapeutics, 69, 340-345.
23. Lee, T. M., Chou, T. F., & Tsai, C. H. (2003). Effect of pravastatin on cardiomyocyte and ventricular vulnerability in normolipidemic rats after myocardial infarction. Journal of Molecular and Cellular Cardiology, 35, 1449-1459.
24. Lee, T. M., Lin, M. S., Chou, T. F., Tsai, C. H., & Chang, N. C. (2004). Effect of pravastatin on left ventricular mass by activation of myocardial K ATP channels in hypercholesterolemic rabbits. Atherosclerosis, 176, 273-278.
25. Levine, B., & Yuan, J. (2005). Autophagy in cell death: An innocent convict? Journal of Clinical Investigation, 115, 2679-2688.
26. Luo, J. D., Zhang, W. W., Zhang, G. P., Guan, J. X., & Chen, X. (1999). Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis. Clinical and Experimental Pharmacology and Physiology, 26, 903-908.
27. Melchert, R. B., Liu, H., Granberry, M. C., & Kennedy, R. H. (2001). Lovastatin inhibits phenylephrine-induced ERK activation and growth of cardiac cells. Cardiovascular Toxicology, 1, 237-252.
28. Nadano, D., & Sato, T. A. (2000). Caspase-3-dependent and -independent degradation of 28 S ribosomal RNA may be involved in the inhibition of protein synthesis during apoptosis initiated by death receptor engagement. Journal of Biological Chemistry, 275, 13967-13973.
29. Nepomnyashchikh, L. M. (2001). Regenerative and plastic insufficiency of cardiomyocytes during impairment of protein synthesis. Bulletin of Experimental Biology & Medicine, 131, 6-14.
30. Nishikawa, H., Miura, S., Zhang, B., Shimomura, H., Arai, H., Tsuchiya, Y., Matsuo, K., & Saku, K. (2004). Statins induce the regression of left ventricular mass in patients with angina. Circulation Journal, 68, 121-125.
31. Ogata, Y., Takahashi, M., Takeuchi, K., Ueno, S., Mano, H., Ookawara, S., Kobayashi, E., Ikeda, U., & Shimada, K. (2002). Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: A possible mechanism of statin-attenuated cardiac hypertrophy. Journal of Cardiovascular Pharmacology, 40, 907-915.
32. Oi, S., Haneda, T., Osaki, J., Kashiwagi, Y., Nakamura, Y., Kawabe, J., & Kikuchi, K. (1999) Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells. European Journal of Pharmacology, 376, 139-148.
33. Olender, E. H., & Simon, R. D. (1992). The intracellular targeting and membrane topology of 3-hydroxy-3-methylglutaryl-CoA reductase. Journal of Biological Chemistry, 267, 4223-4235.
34. Patel, R., Nagueh, S. F., Tsybouleva, N., Abdellatif, M., Lutucuta, S., Kopelen, H. A., Quinones, M. A., Zoghbi, W. A., Entman, M. L., Roberts, R., & Marian, A. J. (2001). Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation, 104, 317-324.
35. Querin, S., Lambert, R., Cusson, J. R., Gregoire, S., Vickers, S., Stubbs, R. J., Sweany, A. E., & Larochelle, P. (1991). Single-dose pharmacokinetics of 14C-lovastatin in chronic renal failure. Clinical Pharmacology and Therapeutics, 50, 437-441.
36. Rabkin, S. W. (2002). Lovastatin induces cell death in cardiomyocytes that is not reversible by coenzyme Q 10. Pharmacology and Toxicology, 90, 343-345.
37. Rabkin, S. W., Goutsouliak, V., & Kong, J. Y. (1997). Angiotensin II induces activation of phosphatidylinositol 3-kinase in cardiomyocytes. Journal of Hypertension, 15, 891-899.
38. Rabkin, S. W., & Kong, J. Y. (2003). Lovastatin-induced cardiac toxicity involves both oncotic and apoptotic cell death with the apoptotic component blunted by both caspase-2 and caspase-3 inhibitors. Toxicology and Applied Pharmacology, 193, 346-355.
39. Rao, R. V., Ellerby, H. M., & Bredesen, D. E. (2004). Coupling endoplasmic reticulum stress to the cell death program. Cell Death and Differentiation, 11, 372-380.
40. Rhoads, R. E. (1999). Signal transduction pathways that regulate eukaryotic protein synthesis. Journal of Biological Chemistry, 274, 30337-30340.
41. Sanada, S., Node, K., Asanuma, H., Ogita, H., Takashima, S., Minamino, T., Asakura, M., Liao, Y., Ogai, A., Kim, J., Hori, M., & Kitakaze, M. (2002). Opening of the adenosine triphosphate-sensitive potassium channel attenuates cardiac remodeling induced by long-term inhibition of nitric oxide synthesis: role of 70-kDa S6 kinase and extracellular signal-regulated kinase. Journal of American College of Cardiology, 40, 991-997.
42. Takahashi, M., Ogata, Y., Okazaki, H., Takeuchi, K., Kobayashi, E., Ikeda, U., & Shimada, K. (2002). Fluvastatin enhances apoptosis in cytokine-stimulated vascular smooth muscle cells. Journal of Cardiovascular Pharmacology, 39, 310-317.
43. Takemoto M., Node, K., Nakagami, H., Liao, Y., Grimm, M., Takemoto, Y., Kitakaze, M., & Liao, J. K. (2001). Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy Journal of Clinical Investigation, 108, 1429-1437.
44. Unlu, S., Clunn, G., Schachter, M., Demoliou-Mason, C., & Hughes, A. D. (2001). Action of an HMG CoA reductase inhibitor, lovastatin, on apoptosis of untransformed and ts-SV40 transformed human smooth muscle cells derived from saphenous vein. Journal of Cardiovascular Pharmacology, 38, 161-173.
45. Verma, S., Rao, V., Weisel, R. D., Li, S.H., Fedak, P. W., Miriuka, S., & Li, R. K. (2004). Novel cardioprotective effects of pravastatin in human ventricular cardiomyocytes subjected to hypoxia and reoxygenation: Beneficial effects of statins independent of endothelial cells. Journal of Surgical Research, 119, 66-71.
46. Wang, I. K., Lin-Shiau, S. Y., & Lin, J. K. (2000). Induction of apoptosis by lovastatin through activation of caspase-3 and DNase II in leukaemia HL-60 cells. Pharmacology and Toxicology, 86, 83-91.
47. Warshaw, J. B. (1972). Cellular energy metabolism during fetal development II. Fatty acid oxidation by the developing heart IV Fatty acid activation, acyl transfer and fatty acid oxidation during development of the chick and rat. Developmental Biology, 28, 537-544.
48. Wertz, I. E., & Hanley, M. R. (1996). Diverse molecular provocation of programmed cell death. Trends in Biochemical Sciences, 21, 359-364.
49. Wong, W. W., Dimitroulakos, J., Minden, M. D., & Penn, L. Z. (2002). HMG-CoA reductase inhibitors and the malignant cell: The statin family of drugs as triggers of tumor-specific apoptosis. Leukemia, 16, 508-519.
50. Zhong, W. B., Wang, C. Y., Chang, T. C., & Lee, W. S. (2003). Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis. Endocrinology, 144, 3852-3859.
51. Zou, Y., Takano, H., Akazawa, H., Nagai, T., Mizukami, M., & Komuro, I. (2002). Molecular and cellular mechanisms of mechanical stress-induced cardiac hypertrophy. Endocrine Journal, 49, 1-13.